Ping, Z., Siegal, G. P., Harada, S., Eltoum, I., Youssef, M., Shen, T., . . . Shen, D. (2016). ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast. Oncotarget.
Chicago-tyylinen lähdeviittausPing, Zheng, et al. "ERBB2 Mutation Is Associated With a Worse Prognosis in Patients With CDH1 Altered Invasive Lobular Cancer of the Breast." Oncotarget 2016.
MLA-viitePing, Zheng, et al. "ERBB2 Mutation Is Associated With a Worse Prognosis in Patients With CDH1 Altered Invasive Lobular Cancer of the Breast." Oncotarget 2016.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.